The global testosterone replacement therapy market size is anticipated to enlarge during the forecast period. Growing media attention and ongoing research for safe use of testosterone is expected to trigger the market growth in the following years. Testosterone replacement therapy (TRT) is recommended to enhance sexual function, muscle strength, body composition and cognition. Also, the commercial market for TRT is gaining a huge momentum attributing to the regular symposium led by industry experts. The market has reported to witness a threefold rise in the past few years. Testosterone is a vital component for development & maintenance of physiological functions in males by exerting a biological effect. For instance in males, this hormone is produced in the testes driven by a hormone secretion in pituitary gland. In females, testosterone is produced in ovaries and adrenal gland and to further produce oestrogen. Biologically, aging indicates the sign of decline in the levels of testosterone on an annual basis. TRT is a recommended treatment for particular cases wherein FDA approved indications such as decrease in sperm production followed by other signs and symptoms exist. For instance, hypogonadism in males is a major condition arising out of hypothalamus or pituitary dysfunction is one such case for TRT diagnosis. In women, breast cancer and vasomotor symptoms indicate the decrease in levels of testosterone. Access "118" page research report with TOC on "Testosterone Replacement Therapy Market" available with Radiant Insights, [email protected] https://www.radiantinsights.com/research/2013-2028-report-on-global-testosterone-replacement-therapy-market Testosterone replacement therapy market is driven by rise in research activities for determining therapy drugs for testosterone deficiency in males. In addition, lifestyle disorders and high consumption of sedatives in male population triggers the demand for therapeutic drugs. Healthcare developments in oncology allows replacement therapy to be a safe choice for treatment for prostate cancer or androgen deficiency. This is turn impels in a significant market share throughout the forecast period. By region, the testosterone replacement therapy market can be segmented as North America, South America, Europe, Asia Pacific, Middle-East and Africa. Europe is a growing market for testosterone replacement therapy and is mainly driven by incidences of decreasing level of testosterone in the geriatric male population. Increasing awareness for replacement therapies is thus supplementing the market demand. In addition, the presence of key players and availability of a suitable healthcare infrastructure with positive aspects for replacement therapy drugs is propelling the market growth. Some of the key players in the testosterone replacement therapy market are Actavis, Bayer, Pfizer, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Acerus Pharmaceuticals, and Novartis.
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.